Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment.

Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID.

J Gen Virol. 2010 Feb;91(Pt 2):382-8. doi: 10.1099/vir.0.015388-0. Epub 2009 Oct 21.

PMID:
19846672
2.

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, Gerken G, Schlaak JF.

Gut. 2010 Aug;59(8):1111-9. doi: 10.1136/gut.2009.195545.

PMID:
20639253
3.

The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.

Chen L, Li S, McGilvray I.

Int J Biochem Cell Biol. 2011 Oct;43(10):1427-31. doi: 10.1016/j.biocel.2011.06.006. Epub 2011 Jun 16. Review.

PMID:
21704181
4.

Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A.

Kim MJ, Yoo JY.

J Immunol. 2010 Oct 1;185(7):4311-8. doi: 10.4049/jimmunol.1000098. Epub 2010 Sep 1.

5.

Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway In Vitro.

Li Y, Li S, Duan X, Chen Y, Jiao B, Ye H, Yao M, Chen L.

Mediators Inflamm. 2016;2016:7417648. Epub 2016 Oct 27.

6.

Retinoic acid-induced protein ISGylation is dependent on interferon signal transduction.

Dao CT, Luo JK, Zhang DE.

Blood Cells Mol Dis. 2006 May-Jun;36(3):406-13. Epub 2006 May 2.

PMID:
16647867
7.

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector.

Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR.

Hepatology. 2005 Sep;42(3):702-10.

PMID:
16108059
8.

Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.

Bautista D, Bermúdez-Silva FJ, Lasarte JJ, Rodriguez-Fonseca F, Baixeras E.

J Pathol. 2007 Nov;213(3):347-55.

PMID:
17940994
9.

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.

Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C.

Hepatology. 2003 May;37(5):1180-8.

PMID:
12717400
10.

Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.

Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.

Rev Invest Clin. 2002 Jan-Feb;54(1):41-50.

PMID:
11995406
11.

Hepatitis C virus reveals a novel early control in acute immune response.

Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, Wakita T, Meurs EF.

PLoS Pathog. 2011 Oct;7(10):e1002289. doi: 10.1371/journal.ppat.1002289. Epub 2011 Oct 13.

12.

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.

Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, Maekawa S, Enomoto N, Watanabe M.

J Viral Hepat. 2006 Oct;13(10):690-700.

PMID:
16970601
13.

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

Duong FH, Filipowicz M, Tripodi M, La Monica N, Heim MH.

Gastroenterology. 2004 Jan;126(1):263-77.

PMID:
14699505
14.

Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.

Ma XZ, Bartczak A, Zhang J, He W, Shalev I, Smil D, Chen L, Phillips J, Feld JJ, Selzner N, Levy G, McGilvray I.

J Virol. 2014 Jun;88(11):6195-204. doi: 10.1128/JVI.03801-13. Epub 2014 Mar 19.

15.

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.

Knolle PA, Kremp S, Höhler T, Krummenauer F, Schirmacher P, Gerken G.

J Viral Hepat. 1998 Nov;5(6):399-406.

PMID:
9857349
16.
17.

Modulation of alpha interferon anti-hepatitis C virus activity by ISG15.

Chua PK, McCown MF, Rajyaguru S, Kular S, Varma R, Symons J, Chiu SS, Cammack N, Nájera I.

J Gen Virol. 2009 Dec;90(Pt 12):2929-39. doi: 10.1099/vir.0.013128-0. Epub 2009 Aug 5.

PMID:
19656964
18.

Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.

Tokumoto Y, Hiasa Y, Uesugi K, Watanabe T, Mashiba T, Abe M, Kumagi T, Ikeda Y, Matsuura B, Onji M.

J Infect Dis. 2012 Apr 1;205(7):1121-30. doi: 10.1093/infdis/jis025. Epub 2012 Feb 21.

PMID:
22357660
19.

Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.

Karino Y, Toyota J, Sugawara M, Miyazaki K, Kuwata Y, Yamazaki K, Sato T, Ohmura T, Matsushima T.

J Gastroenterol Hepatol. 2003 Apr;18(4):404-10.

PMID:
12653888
20.

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.

Pawlotsky JM.

Antiviral Res. 2003 Jun;59(1):1-11. Review.

PMID:
12834855

Supplemental Content

Support Center